Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025;25(2):86-98.
doi: 10.2174/0118715206330232240913100744.

Acyl Urea Compounds Therapeutics and its Inhibition for Cancers in Women: A Review

Affiliations
Review

Acyl Urea Compounds Therapeutics and its Inhibition for Cancers in Women: A Review

Preeti Kumari et al. Anticancer Agents Med Chem. 2025.

Abstract

Acyl urea compounds have garnered significant attention in cancer therapeutics, particularly for their potential effectiveness against cancers that predominantly affect women, such as breast and ovarian cancers. The paper presents a report on the investigation of acyl urea compounds that are reported to involve a multi-faceted approach, including synthetic chemistry, biological assays, and computational modeling. A wealth of information on acyl urea and its purported effects on cancer affecting women has been gathered from different sources and condensed to provide readers with a broad understanding of the role of acyl urea in combating cancer. Acylureas demonstrate promising results by selectively inhibiting key molecular targets associated with cancer progressions, such as EGFR, ALK, HER2, and the Wnt/β-catenin signaling pathway. Specifically, targeting acyl ureas impedes tumor proliferation and metastasis while minimizing harm to healthy tissues, offering a targeted therapeutic approach with reduced side effects compared to conventional chemotherapy. Continued research and clinical trials are imperative to optimize the efficacy and safety profiles of acylurea-based therapies and broaden their applicability across various cancer types. Acyl urea compounds represent a promising class of therapeutics for the treatment of cancers in women, particularly due to their ability to selectively inhibit key molecular targets involved in tumor growth and progression. The combination of synthetic optimization, biological evaluation, and computational modeling has facilitated the identification of several lead compounds with significant anticancer potential. This abstract explores the therapeutic mechanisms and targeted pathways of acyl ureas in combating these malignancies, which will be useful for future studies.

Keywords: Acylurea; breast cancer.; chemotherapy; colorectal cancer; signaling pathways; targets.

PubMed Disclaimer

Similar articles

References

    1. Kumari P.; Mishra R.; Mazumder R.; Mazumder A.; Singh A.; Singh G.; Tyagi P.K.; An insight into common and advanced synthesis methodologies of acyl urea analogs targeting the CNS. Lett Org Chem 2024,21(12),1006-1022 - DOI
    1. Chaudhary R.; Shuaib M.; Hashim S.R.; Mishra P.S.; Synthesis, characterization and antitumor potential of cinnamoyl urea derivatives. Asian J Chem 2016,28(2),410-414 - DOI
    1. Mishra R.; Mazumder A.; Mazumder R.; Mishra P.S.; Chaudhary P.; Docking study and result conclusion of heterocyclic derivatives having urea and acyl moiety. Asian J Biomed Pharm Sci 2019,9(67),13 - DOI
    1. Martinez M.E.; Schmeler K.M.; Lajous M.; Newman L.A.; Cancer screening in low- and middle-income countries. Am Soc Clin Oncol Educ Book 2024,44(3),e431272 - DOI - PubMed
    1. Saggu S.; Rehman H.; Abbas Z.K.; Ansari A.A.; Recent incidence and descriptive epidemiological survey of breast cancer in Saudi Arabia. Saudi Med J 2015,36(10),1176-1180 - DOI - PubMed

MeSH terms